Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

Financial Services Healthcare
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

GlobeNewswire August 7, 2023

GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options

GlobeNewswire July 19, 2023

GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

GlobeNewswire July 18, 2023

GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium

GlobeNewswire June 28, 2023

GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants

GlobeNewswire June 26, 2023

GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients

GlobeNewswire June 20, 2023

GeneDx to Participate in Upcoming Investor Conferences in June

GlobeNewswire May 24, 2023

GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations

GlobeNewswire May 23, 2023

GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire May 22, 2023

GeneDx Reports First Quarter 2023 Financial Results and Business Highlights

GlobeNewswire May 9, 2023

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

GlobeNewswire May 4, 2023

GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders

GlobeNewswire May 3, 2023

GeneDx Announces Reverse Stock Split

GlobeNewswire April 28, 2023

GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

GlobeNewswire April 18, 2023

GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel

GlobeNewswire April 3, 2023

GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease "Diagnostic Odyssey"

GlobeNewswire March 20, 2023

GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray

GlobeNewswire March 16, 2023

GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

GlobeNewswire March 14, 2023

GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference

GlobeNewswire March 1, 2023

GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting

GlobeNewswire February 28, 2023